Substance P and neurodegenerative disorders. A speculative review
- PMID: 1724684
- DOI: 10.1016/0143-4179(91)90054-m
Substance P and neurodegenerative disorders. A speculative review
Abstract
The causes of the neurodegenerative disorders of Parkinson's disease (PD), Alzheimer's disease (AD) and amyotrophic lateral sclerosis (ALS) are unknown. It is proposed that all these disorders result primarily from a loss of trophic peptidergic neurotransmitter, possibly Substance P (SP). This loss in turn produces the classical neuronal degeneration seen in each of these diseases and occurs due to a combination of natural aging and chronic autoimmune destruction following a viral infection of the CNS, early in life. The loss is therefore slow and by the time of clinical presentation the inflammatory process is disappearing as the antigenic stimulus lessens with its removal. The implications of the theory in terms of future research and therapy are briefly discussed.
Similar articles
-
Hospital-treated infections in early- and mid-life and risk of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis: A nationwide nested case-control study in Sweden.PLoS Med. 2022 Sep 15;19(9):e1004092. doi: 10.1371/journal.pmed.1004092. eCollection 2022 Sep. PLoS Med. 2022. PMID: 36107840 Free PMC article.
-
Neurotoxicity as a mechanism for neurodegenerative disorders: basic and clinical aspects.Expert Opin Investig Drugs. 2001 May;10(5):985-9. doi: 10.1517/13543784.10.5.985. Expert Opin Investig Drugs. 2001. PMID: 11424902 Review.
-
Theories of neurodegeneration.Ann N Y Acad Sci. 1992 May 11;648:1-5. doi: 10.1111/j.1749-6632.1992.tb24518.x. Ann N Y Acad Sci. 1992. PMID: 1637039 Review. No abstract available.
-
Trophic factors in neurologic disease.Annu Rev Med. 1988;39:193-201. doi: 10.1146/annurev.me.39.020188.001205. Annu Rev Med. 1988. PMID: 3285771 Review.
-
Are Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis caused by neurotoxins?Del Med J. 1987 Aug;59(8):533-4, 537. Del Med J. 1987. PMID: 3666247 No abstract available.
Cited by
-
Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential.CNS Drugs. 2005;19(4):275-93. doi: 10.2165/00023210-200519040-00001. CNS Drugs. 2005. PMID: 15813642 Review.
-
Using Gelatin Nanoparticle Mediated Intranasal Delivery of Neuropeptide Substance P to Enhance Neuro-Recovery in Hemiparkinsonian Rats.PLoS One. 2016 Feb 19;11(2):e0148848. doi: 10.1371/journal.pone.0148848. eCollection 2016. PLoS One. 2016. PMID: 26894626 Free PMC article.
-
5-hydroxytryptamine (5-HT)1A autoreceptor adaptive changes in substance P (neurokinin 1) receptor knock-out mice mimic antidepressant-induced desensitization.J Neurosci. 2001 Oct 15;21(20):8188-97. doi: 10.1523/JNEUROSCI.21-20-08188.2001. J Neurosci. 2001. PMID: 11588191 Free PMC article.
-
Sequence-specific effects of neurokinin substance P on memory, reinforcement, and brain dopamine activity.Psychopharmacology (Berl). 1993;112(2-3):147-62. doi: 10.1007/BF02244906. Psychopharmacology (Berl). 1993. PMID: 7532865 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous